APA
Dickinson G. L., Rezaee S., Proctor N. J., Lennard M. S., Tucker G. T. & Rostami-Hodjegan A. (20070412). Incorporating in vitro information on drug metabolism into clinical trial simulations to assess the effect of CYP2D6 polymorphism on pharmacokinetics and pharmacodynamics: dextromethorphan as a model application. : Journal of clinical pharmacology.
Chicago
Dickinson Gemma L, Rezaee Saeed, Proctor Nicholas J, Lennard Martin S, Tucker Geoffrey T and Rostami-Hodjegan Amin. 20070412. Incorporating in vitro information on drug metabolism into clinical trial simulations to assess the effect of CYP2D6 polymorphism on pharmacokinetics and pharmacodynamics: dextromethorphan as a model application. : Journal of clinical pharmacology.
Harvard
Dickinson G. L., Rezaee S., Proctor N. J., Lennard M. S., Tucker G. T. and Rostami-Hodjegan A. (20070412). Incorporating in vitro information on drug metabolism into clinical trial simulations to assess the effect of CYP2D6 polymorphism on pharmacokinetics and pharmacodynamics: dextromethorphan as a model application. : Journal of clinical pharmacology.
MLA
Dickinson Gemma L, Rezaee Saeed, Proctor Nicholas J, Lennard Martin S, Tucker Geoffrey T and Rostami-Hodjegan Amin. Incorporating in vitro information on drug metabolism into clinical trial simulations to assess the effect of CYP2D6 polymorphism on pharmacokinetics and pharmacodynamics: dextromethorphan as a model application. : Journal of clinical pharmacology. 20070412.